Smith & Nephew (SNN) Divestments (2018)
Smith & Nephew (SNN) posted quarterly Divestments of $9.0 million for Q4 2018.
Smith & Nephew (SNN) Divestments (2018) Analysis & Trends
Smith & Nephew (SNN) has reported Divestments for 1 consecutive years, with $9.0 million the latest figure, recorded in Q4 2018.
- Quarterly Divestments changed N/A year-over-year to $9.0 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $17.2 million (changed N/A YoY) and the FY2020 annual result came in at $51.0 million, changed 0.0% from the prior year.
- Divestments steadied at $9.0 million in Q4 2018 per SNN's latest filing.
- Over the last five years, Divestments for SNN reached as high as $9.0 million in Q4 2018 and fell as low as $9.0 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.37 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 9.00 Mn |